CARE (CARE)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$725.27M
EV / Sales2.08
EV / EBITDA4.23
EV / Operating Cash Flow2.21
EV / Free Cash Flow2.25

Return Metrics (TTM)

Return on Equity (ROE)27.40%
Return on Assets (ROA)2.68%
Return on Invested Capital (ROIC)2.68%
Return on Capital Employed (ROCE)3.45%

Yield Metrics

Earnings Yield17.02%
Free Cash Flow Yield41.97%

Balance Sheet Strength

Net Debt / EBITDA-0.24
Current Ratio0.00
Working Capital$41.10M
Tangible Asset Value$537.14M
Net Current Asset Value-$4.22B

Working Capital Efficiency

Days Sales Outstanding0.00
Days Payables Outstanding0.00
Operating Cycle (Days)0.00
Cash Conversion Cycle0.00

Capital Allocation

CapEx / Revenue1.77%
CapEx / Operating Cash Flow1.88%
R&D / Revenue0.00%
SG&A / Revenue21.48%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin61.68%
Operating Margin15.71%
Net Profit Margin12.32%

Solvency

Debt / Equity0.43
Quick Ratio0.12
Cash Ratio0.02

Per Share

Revenue / Share$11.34
FCF / Share$1.42
PE Ratio14.04